These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Pasteurellosis and bacteria EF 4, M5 and II J: pathogenic role in man following animal bites and bacterial sensitivity. Canton P; May T; Burdin J; Lion C Chemioterapia; 1987 Jun; 6(2 Suppl):26-8. PubMed ID: 3509405 [No Abstract] [Full Text] [Related]
44. [Significance of non-fermentative gram-negative bacteria in infections. Bacteriological and clinical aspects]. Turcu T; Liscă M Rev Med Chir Soc Med Nat Iasi; 1981; 85(2):275-82. PubMed ID: 7051218 [No Abstract] [Full Text] [Related]
45. In vitro activity of RO 19-5247 (T-2525) against intestinal pathogens, glucose non-fermentative gram-negative rods, Legionella and Serratia. Hohl P; Von Graevenitz A; Zollinger-Iten J Chemioterapia; 1987 Jun; 6(2 Suppl):98-101. PubMed ID: 3509545 [No Abstract] [Full Text] [Related]
46. Processing of data relative to gram-negative bacterial strains of clinical origin isolated in the three-year period 1972/1974. Salvetti ME; Coletta P Antibiotica; 1975 Dec; 13(4):188-241. PubMed ID: 1235770 [No Abstract] [Full Text] [Related]
47. Epidemiology of aminoglycoside resistance in a large animal hospital. Orsini JA; Spencer P Equine Vet J; 1997 Jul; 29(4):319-21. PubMed ID: 15338914 [No Abstract] [Full Text] [Related]
48. Paradoxical effect of aminoglycoside antibiotics on the growth of Gram-negative bacilli. Lorian V; Silletti RP; Biondo FX; De Freitas CC J Antimicrob Chemother; 1979 Sep; 5(5):613-6. PubMed ID: 500518 [No Abstract] [Full Text] [Related]
49. Processing of data relative to gram-positive bacterial strains of clinical origin isolated in the three-year period 1972/1974. Salvetti ME; Alfonsi D Antibiotica; 1975; 13(2-3):110-67. PubMed ID: 1235768 [No Abstract] [Full Text] [Related]
50. Recommendations for the calculation of the post-antibiotic effect for beta-lactams and gram-negative bacilli. Kroeker JS; Karlowsky JA; Zhanel GG J Antimicrob Chemother; 1995 Apr; 35(4):551-2. PubMed ID: 7628990 [No Abstract] [Full Text] [Related]
51. Activity of RX-P873, a novel pyrrolocytosine, against Gram-negative bacteria. Morrissey I; Magnet S; Genet E; Jeandey P; Marra A; Hawser S; Duffy E Int J Antimicrob Agents; 2015 Sep; 46(3):352-4. PubMed ID: 26159867 [No Abstract] [Full Text] [Related]
52. [The problems of chemotherapy from a bacteriological point of view: recent alternation of bacterial resistance. B. Gram negative bacilli]. Kanno H Nihon Saikingaku Zasshi; 1987 Nov; 42(6):823-35. PubMed ID: 3329245 [No Abstract] [Full Text] [Related]
53. Enhancing uptake of antibiotics into Gram-negative bacteria using nonribosome-targeting aminoglycoside-based adjuvants. Schweizer F Future Med Chem; 2019 Jul; 11(13):1519-1522. PubMed ID: 31469333 [No Abstract] [Full Text] [Related]
54. [In vitro sensitivity of 320 bacterial strains, isolated from urine culture, to 12 microbial agents]. Riviera L; Mattina R Ann Sclavo; 1982; 24(5):503-12. PubMed ID: 7188244 [No Abstract] [Full Text] [Related]